Blue Horseshoe Stocks: VTEQ Report

VeriTeQ Corporation (VTEQ)

We’ve got a new interest to present this morning that is catching our attention for a number of reasons. VTEQ, in addition to being in a good place on the chart with regard to upside potential (more on that in a minute), operates in an interesting market sector.

The company develops proprietary RFID (Radio Frequency Identification) technologies for use in implantable medical devices. It’s rare to find a development-stage company like VeriTeq which has an established product line in this arena, and that’s another reason why we think running across the stock at this stage of the game could end up working in our favor.

Not including those in future plans for development, VTEQ has two primary technologies of note:

Q Inside Safety Technology –  Last year the FDA issued a “Final Rule” on Unique Device Identification (UDI). Under this rule, each medical device must be labeled with a unique device identifier, and the labeler must submit information concerning each device to FDA’s Global Unique Device Identification Database (GUDID).

VTEQ’s Q Inside Safety Tech uses an FDA-Cleared Passive RFID chip for UDI in everything from medical implants to artificial joints.  It allows medical professionals to use a handheld scanner to access device data quickly and efficiently  (i.e. serial number, lot number etc.) which could save lives in the event of device recalls. According to a press release out on Tuesday, more than 1000 women worldwide have already received breast implants which implement the product. >>> READ PR

RFID Dosimeter Technology – Radiation overdose is a very real threat associated with CT scans and radiation therapy, and VTEQ’s Dosimeters address that risk directly. By reporting and recording the radiation levels being delivered to a patient in real time, this technology also has life-saving potential. The dosimeters are available in implantable and external versions (pictured below)

These technologies are designed to work with VTEQ’s Informatics and Data Analytics platform currently under development, and are indicative of the medical profession’s move to digital record-keeping which has been taking place over the past several years.

CHART COMMENTARY:

Fortunately, operating in an interesting market sector isn’t the only thing drawing us to VTEQ; the chart is in a good position with what we feel is significant upside potential. The stock is oversold, yet it has been recording higher lows off of its recent bottom. A breakout from here is definitely a possibility so we’re going to have VTEQ on close watch:

FROM THIS WEEK’S NEWS FEED:

For More Information on VTEQ and its Technologies Visit:
www.VeriTeqCorp.com